Literature DB >> 15040773

Retinitis pigmentosa: understanding the clinical presentation, mechanisms and treatment options.

Michael Kalloniatis1, Erica L Fletcher.   

Abstract

Retinitis pigmentosa (RP) is a leading cause of human blindness due to degeneration of retinal photoreceptor cells. Causes of retinal degeneration include defects in the visual pigment, defects in the proteins important for photoreceptor function or in enzymes involved in initiating visual transduction. Despite the diversity of genetic mutations identified in inherited forms of retinal dystrophy, there is a common end result of photoreceptor death and functional blindness. In this review, pertinent anatomical and physiological pathways involved in RP and the underlying genetic mutations are outlined, including a discussion on the inheritance patterns revealed by advances in molecular biological techniques. Characteristics of progression rates of visual field loss and current management options will provide useful clinical guidelines for the management of patients with RP.

Entities:  

Mesh:

Year:  2004        PMID: 15040773     DOI: 10.1111/j.1444-0938.2004.tb03152.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  27 in total

Review 1.  Pre-mRNA splicing and retinitis pigmentosa.

Authors:  Daniel Mordes; Xiaoyan Luo; Amar Kar; David Kuo; Lili Xu; Kazuo Fushimi; Guowu Yu; Paul Sternberg; Jane Y Wu
Journal:  Mol Vis       Date:  2006-10-26       Impact factor: 2.367

2.  Evidence for retinal remodelling in retinitis pigmentosa caused by PDE6B mutation.

Authors:  Samuel G Jacobson; Alexander Sumaroka; Tomas S Aleman; Artur V Cideciyan; Michael Danciger; Debora B Farber
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

Review 3.  Gene replacement therapy for retinal CNG channelopathies.

Authors:  Christian Schön; Martin Biel; Stylianos Michalakis
Journal:  Mol Genet Genomics       Date:  2013-07-17       Impact factor: 3.291

Review 4.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

5.  Visual restoration and transplant connectivity in degenerate rats implanted with retinal progenitor sheets.

Authors:  M J Seiler; R B Aramant; B B Thomas; Q Peng; S R Sadda; H S Keirstead
Journal:  Eur J Neurosci       Date:  2010-01-25       Impact factor: 3.386

6.  Mutation-independent rescue of a novel mouse model of Retinitis Pigmentosa.

Authors:  D L Greenwald; S M Cashman; R Kumar-Singh
Journal:  Gene Ther       Date:  2012-07-19       Impact factor: 5.250

7.  Thermal stability of rhodopsin and progression of retinitis pigmentosa: comparison of S186W and D190N rhodopsin mutants.

Authors:  Monica Yun Liu; Jian Liu; Devi Mehrotra; Yuting Liu; Ying Guo; Pedro A Baldera-Aguayo; Victoria L Mooney; Adel M Nour; Elsa C Y Yan
Journal:  J Biol Chem       Date:  2013-04-26       Impact factor: 5.157

8.  Blood flow and anatomical MRI in a mouse model of retinitis pigmentosa.

Authors:  Eric R Muir; Bryan De La Garza; Timothy Q Duong
Journal:  Magn Reson Med       Date:  2012-03-05       Impact factor: 4.668

9.  Chemical kinetic analysis of thermal decay of rhodopsin reveals unusual energetics of thermal isomerization and hydrolysis of Schiff base.

Authors:  Jian Liu; Monica Yun Liu; Li Fu; Gefei Alex Zhu; Elsa C Y Yan
Journal:  J Biol Chem       Date:  2011-09-15       Impact factor: 5.157

10.  Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa.

Authors:  Xue Cai; Shannon M Conley; Zack Nash; Steven J Fliesler; Mark J Cooper; Muna I Naash
Journal:  FASEB J       Date:  2009-12-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.